2026年11月5日星期四
M
विश्व व्यापक संदर्भ
वैश्विक ताज़ा ख़बरें
Japan's Yamato targets 'leaner' delivery service in push for profit: president— 日经 Nikkei AsiaToyota to bring Celica back to premier rally racing after 32-year break— 日经 Nikkei AsiaU.S. Steel grows to 40% of Nippon Steel profit as prices surge— 日经 Nikkei AsiaThe price of building Japanese stealth frigates in Australia— 日经 Nikkei AsiaMcDonald's wages war on KFC in Japan as consumers crave chicken— 日经 Nikkei AsiaJapan's Koito looks to keep lighting way with smart automotive lamps— 日经 Nikkei AsiaAnalysis: How a secret feud ignited Xi Jinping's governance drive— 日经 Nikkei AsiaJapan lender leads $600m credit line to help Malaysia's Petronas cut CO2— 日经 Nikkei AsiaJapan's Yamato targets 'leaner' delivery service in push for profit: president— 日经 Nikkei AsiaToyota to bring Celica back to premier rally racing after 32-year break— 日经 Nikkei AsiaU.S. Steel grows to 40% of Nippon Steel profit as prices surge— 日经 Nikkei AsiaThe price of building Japanese stealth frigates in Australia— 日经 Nikkei AsiaMcDonald's wages war on KFC in Japan as consumers crave chicken— 日经 Nikkei AsiaJapan's Koito looks to keep lighting way with smart automotive lamps— 日经 Nikkei AsiaAnalysis: How a secret feud ignited Xi Jinping's governance drive— 日经 Nikkei AsiaJapan lender leads $600m credit line to help Malaysia's Petronas cut CO2— 日经 Nikkei Asia

Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia

स्रोत Nature 生命科学1 दिन पहले
सामग्री सारांश

यह साइट केवल शीर्षक और सारांश सूचकांक प्रदान करती है, पूरी सामग्री और कॉपीराइट मूल प्रकाशक के पास हैं, कृपया मूल लिंक पर क्लिक करके पढ़ें।

मूल पाठ पर जाएं
संबंधित चैनल
विज्ञान
संबंधित क्षेत्र
वैश्विक दृष्टिकोण
मूल भाषा
English
प्रविष्टि संख्या
science-5e9eca3a

Comments 0 comments

No comments yet. Be the first.

Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia · विश्व व्यापक संदर्भ